Favipiravir Effectiveness and Safety in Hospitalized Moderate-Severe COVID-19 Patients: Observational Prospective Multicenter Investigation in Saudi Arabia.

导出 LinkOut

翻译打印收藏纠错

作者： Saleh,Al-Muhsen ^[1] ; Nouf S,Al-Numair ^[2] ; Narjes,Saheb Sharif-Askari ^[3] ; Roaa,Basamh ^[4] ; Banan,Alyounes ^[4] ; Amjad,Jabaan ^[4] ; Fatemeh,Saheb Sharif-Askari ^[3] ; Mohammed F,Alosaimi ^[1] ; Fahad,Alsohime ^[1] ; Rabih,Halwani ^[1] ; Haya,Al-Saud ^[3]

作者单位： Immunology Research Laboratory, Department of Pediatrics, College of Medicine and King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia. ^[1] The Saudi Ministry of Health and Center of Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. ^[2] Sharjah Institute of Medical Research, University of Sharjah, Sharjah, United Arab Emirates. ^[3] King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia. ^[4] Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates. ^[5] Hevolution Foundation, Riyadh, Saudi Arabia. ^[6]

关键词 COVID-19 SARS-CoV-2 favipiravir in-hospital mortality length of hospital stay

DOI 10.3389/fmed.2022.826247

PMID 35308532

发布时间 2022-03-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Frontiers in medicine

2022年9卷

826247页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Favipiravir Effectiveness and Safety in Hospitalized Moderate-Severe COVID-19 Patients: Observational Prospective Multicenter Investigation in Saudi Arabia.

Frontiers in medicine

相似文献

Frontiers in medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Favipiravir Effectiveness and Safety in Hospitalized Moderate-Severe COVID-19 Patients: Observational Prospective Multicenter Investigation in Saudi Arabia.

Frontiers in medicine

相似文献

Frontiers in medicine

相关期刊

检索历史清除